Clinical Trials Browser

NIH × Has results × Nasopharyngeal Carcinoma × Clear all

NCT04458909 2025-10-03

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Phase 3 Terminated

15 enrolled 17 charts

Nasopharyngeal Carcinoma

NCT02339558 2019-09-13

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Phase 2 Completed

45 enrolled 12 charts

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms